Copy number variation and mosaicism

Cytogenetic and Genome Research

Volumn 123, Issue 1-4, 2009, Pages 270-277

  Notini, A J ^a   Craig, J M ^a   White, S J ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERA; DNA SEQUENCE; DUCHENNE MUSCULAR DYSTROPHY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE DELETION; GENE DUPLICATION; GENE FREQUENCY; GENE MUTATION; GENE REARRANGEMENT; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; MONOZYGOTIC TWINS; MOSAICISM; NEUROFIBROMATOSIS; PRIORITY JOURNAL; REVIEW; SOMATIC MUTATION;

DISEASE; GENE DOSAGE; GENOME; HUMANS; MOSAICISM;

EID: 62549107514     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000184717     Document Type: Review

References (72)

1. Armour JA, Sismani C, Patsalis PC, Cross G: Measurement of locus copy number by hybridization with amplifiable probes. Nucleic Acids Res 28:605-609 (2000).
2. Armour JA, Barton DE, Cockburn DJ, Taylor GR: The detection of large deletions or duplications in genomic DNA. Hum Mutat 20:325-337 (2002).
3. Bakker E, Van Broeckhoven C, Bonten EJ, van de Vooren MJ, Veenema H, et al: Germline mosaicism and Duchenne muscular dystrophy mutations. Nature 329:554-556 (1987).
4. Bakker E, Veenema H, den Dunnen JT, van Broeckhoven C, Grootscholten PM, et al: Germinal mosaicism increases the recurrence risk for 'new' Duchenne muscular dystrophy mutations. J Med Genet 26:553-559 (1989).
5. Bakker E, Wijmenga C, Vossen RH, Padberg GW, Hewitt J, et al: The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter. Muscle Nerve 2:S39-44 (1995).
6. Ballif BC, Rorem EA, Sundin K, Lincicum M, Gaskin S, et al: Detection of low-level mosaicism by array CGH in routine diagnostic specimens. Am J Med Genet 140:2757-2767 (2006).
7. Bluth MH, Reid ME, Manny N: Chimerism in the immunohematology laboratory in the molecular biology era. Transfus Med Rev 21:134-146 (2007).
8. Bruder CE, Piotrowski A, Gijsbers AA, Andersson R, Erickson S, et al: Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am J Hum Genet 82:763-771 (2008).
9. Bustamante C, Gurrieri S, Smith SB: Towards a molecular description of pulsed-field gel electrophoresis. Trend Biotech 11:23-30 (1993).
10. Campbell PJ, Stephens PJ, Pleasance ED, O'Meara S, Li H, et al: Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 40:722-729 (2008).
11. Carter NP: Methods and strategies for analyzing copy number variation using DNA microarrays. Nat Genet 39:S16-21 (2007).
12. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R: DNA hypomethylation leads to elevated mutation rates. Nature 395:89-93 (1998).
13. Cheung SW, Shaw CA, Scott DA, Patel A, Sahoo T, et al: Microarray-based CGH detects chromosomal mosaicism not revealed by conventional cytogenetics. Am J Med Genet 143:1679-1686 (2007).
14. den Dunnen JT, Bakker E, Breteler EG, Pearson PL, van Ommen GJ: Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels. Nature 329:640-642 (1987).
15. den Dunnen JT, Grootscholten PM, Bakker E, Blonden LA, Ginjaar HB, et al: Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet 45:835-847 (1989).
16. den Dunnen JT, Grootscholten PM, Dauwerse JG, Walker AP, Monaco AP, et al.: Reconstruction of the 2.4 Mb human DMD-gene by homologous YAC recombination. Hum Mol Genet 1: 19-28 (1992).
17. Erickson RP: Somatic gene mutation and human disease other than cancer. Mutat Res 543:125-136 (2003).
18. Faizunnessa NN, Tsuchiya T, Kumatori A, Kurozumi H, Imajoh-Ohmi S, et al: A 25-kb deletion in the 5′ region of the cytochrome b558 heavy chain gene (CYBB) in a patient with X-linked chronic granulomatous disease. Hum Genet 99: 469-473 (1997).
19. Forrest SM, Cross GS, Speer A, Gardner-Medwin D, Burn J, Davies KE: Preferential deletion of exons in Duchenne and Becker muscular dystrophies. Nature 329:638-640 (1987).
20. Gervasini C, Castronovo P, Bentivegna A, Mottadelli F, Faravelli F, et al: High frequency of mosaic CREBBP deletions in Rubinstein-Taybi syndrome patients and mapping of somatic and germ-line breakpoints. Genomics 90:567-573 (2007).
21. Hall JG: Review and hypotheses: somatic mosaicism: observations related to clinical genetics. Am J Hum Genet 43:355-363 (1988).
22. Higuchi M, Kochhan L, Olek K: A somatic mosaic for haemophilia A detected at the DNA level. Mol Biol Med 5:23-27 (1988).
23. Hirschhorn R: In vivo reversion to normal of inherited mutations in humans. J Med Genet 40:721-728 (2003).
24. Janssen B, Hartmann C, Scholz V, Jauch A, Zschocke J: MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls. Neurogenetics 6:29-35 (2005).
25. Kehrer-Sawatzki H, Kluwe L, Sandig C, Kohn M, Wimmer K, et al: High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene. Am J Hum Genet 75:410-423 (2004).
26. Kenwrick S, Woffendin H, Jakins T, Shuttleworth SG, Mayer E, et al: Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome. Am J Hum Genet 69:1210-1217 (2001).
27. Khan F, Agarwal A, Agrawal S: Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme. Bone Marrow Transplant 34:1-12 (2004).
28. Kidd JM, Cooper GM, Donahue WF, Hayden HS, Sampas N, et al: Mapping and sequencing of structural variation from eight human genomes. Nature 453:56-64 (2008).
29. Kitsberg D, Selig S, Keshet I, Cedar H: Replication structure of the human beta-globin gene domain. Nature 366:588-590 (1993).
30. Klein CJ, Coovert DD, Bulman DE, Ray PN, Mendell JR, Burghes AH: Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet 50:950-959 (1992).
31. Knudson RA, Shearer BM, Ketterling RP: Automated Duet spot counting system and manual technologist scoring using dual-fusion fluorescence in situ hybridization (D-FISH) strategy: comparison and application to FISH minimal residual disease testing in patients with chronic myeloid leukemia. Cancer Genet Cytogenet 175:8-18 (2007).
32. Kozlowski P, Roberts P, Dabora S, Franz D, Bissler J, et al: Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations. Hum Genet 121:389-400 (2007).
33. Lazaro C, Ravella A, Gaona A, Volpini V, Estivill X: Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father. N Engl J Med 331:1403-1407 (1994).
34. Lemmers RJ, van der Maarel SM, van Deutekom JC, van der Wielen MJ, Deidda G, et al: Inter- and intrachromosomal sub-telomeric rearrangements on 4q35: implications for facioscapulohumeral muscular dystrophy (FSHD) aetiology and diagnosis. Hum Mol Genet 7:1207-1214 (1998).
35. Lemmers RJ, van der Wielen MJ, Bakker E, Padberg GW, Frants RR, van der Maarel SM: Somatic mosaicism in FSHD often goes undetected. Annal Neurol 55:845-850 (2004a).
36. Lemmers RJ, Van Overveld PG, Sandkuijl LA, Vrieling H, Padberg GW, et al: Mechanism and timing of mitotic rearrangements in the subtelomeric D4Z4 repeat involved in facioscapulohumeral muscular dystrophy. Am J Hum Genet 75:44-53 (2004b).
37. Liehr T, Claussen U: Current developments in human molecular cytogenetic techniques. Curr Mol Med 2:283-297 (2002).
38. Lissauer D, Piper KP, Moss PA, Kilby MD: Persistence of fetal cells in the mother: friend or foe? BJOG 114:1321-1325 (2007).
39. Lupski JR, Stankiewicz P: Genomic disorders: molecular mechanisms for rearrangements and conveyed phenotypes. PLoS Genet 1:e49 (2005).
40. Mandel JL: Dystrophin. The gene and its product. Nature 339:584-586 (1989).
41. Milewicz DM, Witz AM, Smith AC, Manchester DK, Waldstein G, Byers PH: Parental somatic and germ-line mosaicism for a multiexon deletion with unusual endpoints in a type III collagen ( COL3A1 ) allele produces Ehlers-Danlos syndrome type IV in the heterozygous offspring. Am J Hum Genet 53:62-70 (1993).
42. Najfeld V, Burnett W, Vlachos A, Scigliano E, Isola L, Fruchtman S: Interphase FISH analysis of sex-mismatched BMT utilizing dual color XY probes. Bone Marrow Transplant 19:829-834 (1997).
43. Passos-Bueno MR, Bakker E, Kneppers AL, Takata RI, Rapaport D, et al: Different mosaicism frequencies for proximal and distal Duchenne muscular dystrophy (DMD) mutations indicate difference in etiology and recurrence risk. Am J Hum Genet 51:1150-1155 (1992).
44. Percy ME, Markovic VD, Dalton AJ, McLachlan DR, Berg JM, et al: Age-associated chromosome 21 loss in Down syndrome: possible relevance to mosaicism and Alzheimer disease. Am J Med Genet 45:584-588 (1993).
45. Petek E, Jenne DE, Smolle J, Binder B, Lasinger W, et al: Mitotic recombination mediated by the JJAZF1 (KIAA0160) gene causing somatic mosaicism and a new type of constitutional NF1 microdeletion in two children of a mosaic female with only few manifestations. J Med Genet 40:520-525 (2003).
46. Piotrowski A, Bruder CE, Andersson R, diaz de Stahl T, Menzel U, et al: Somatic mosaicism for copy number variation in differentiated tissues. Hum Mutat 29:1118-1124 (2008).
47. Rasmussen SA, Colman SD, Ho VT, Abernathy CR, Arn PH, et al: Constitutional and mosaic large NF1 gene deletions in neurofibromatosis type 1. J Med Genet 35:468-471 (1998).
48. Repas-Humpe LM, Humpe A, Lynen R, Glock B, Dauber EM, et al: A dispermic chimerism in a 2-year-old Caucasian boy. Ann Hematol 78: 431-434 (1999).
49. Rizwana R, Hahn PJ: CpG methylation reduces genomic instability. J Cell Sci 112:4513-4519 (1999).
50. Roberts RG, Coffey AJ, Bobrow M, Bentley DR: Exon structure of the human dystrophin gene. Genomics 16:536-538 (1993).
51. Schinzel A: Tetrasomy 12p (Pallister-Killian syndrome). J Med Genet 28:122-125 (1991).
52. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 30:e57 (2002).
53. Sgambati MT, Stolle C, Choyke PL, Walther MM, Zbar B, et al: Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents. Am J Hum Genet 66:84-91 (2000).
54. Shaffer LG, Bejjani BA: Medical applications of array CGH and the transformation of clinical cytogenetics. Cytogenet Genome Res 115:303-309 (2006).
55. Sippel KC, Fraioli RE, Smith GD, Schalkoff ME, Sutherland J, et al: Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counseling. Am J Hum Genet 62:610-619 (1998).
56. Smyk M, Obersztyn E, Nowakowska B, Bocian E, Cheung SW, et al: Recurrent SOX9 deletion campomelic dysplasia due to somatic mosaicism in the father. Am J Med Genet 143:866-870 (2007).
57. Steinmann K, Cooper DN, Kluwe L, Chuzhanova NA, Senger C, et al: Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination. Am J Hum Genet 81:1201-1220 (2007).
58. Strain L, Dean JC, Hamilton MP, Bonthron DT: A true hermaphrodite chimera resulting from embryo amalgamation after in vitro fertilization. N Engl J Med 338:166-169 (1998).
59. Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, et al: Evidence for anticipation and association of deletion size with severity in facioscapulo-humeral muscular dystrophy. The FSH-DY Group. Annal Neurol 39:744-748 (1996).
60. Tawil R, Figlewicz DA, Griggs RC, Weiffenbach B: Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. FSH Consortium. Annal Neurol 43: 279-282 (1998).
61. Upadhyaya M, Maynard J, Osborn M, Jardine P, Harper PS, Lunt P: Germinal mosaicism in facioscapulohumeral muscular dystrophy (FSHD). Muscle Nerve 2:S45-49 (1995).
62. van der Maarel SM, Deidda G, Lemmers RJ, van Overveld PG, van der Wielen M, et al: De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10. Am J Hum Genet 66:26-35 (2000).
63. van Deutekom JC, Wijmenga C, van Tienhoven EA, Gruter AM, Hewitt JE, et al: FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet 2:2037-2042 (1993).
64. van Ommen GJ, Breuning MH, Raap AK: FISH in genome research and molecular diagnostics. Curr Opin Genet Dev 5:304-308 (1995).
65. Vissers LE, Veltman JA, van Kessel AG, Brunner HG: Identification of disease genes by whole genome CGH arrays. Hum Mol Genet 14 Spec No. 2:R215-223 (2005).
66. Wheeler DA, Srinivasan M, Egholm M, Shen Y, Chen L, et al: The complete genome of an individual by massively parallel DNA sequencing. Nature 452:872-876 (2008).
67. White SJ, den Dunnen JT: Copy number variation in the genome; the human DMD gene as an example. Cytogenet Genome Res 115:240-246 (2006).
68. White SJ, Aartsma-Rus A, Flanigan KM, Weiss RB, Kneppers AL, et al: Duplications in the DMD gene. Hum Mutat 27:938-945 (2006).
69. Wijmenga C, Hewitt JE, Sandkuijl LA, Clark LN, Wright TJ, et al: Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 2:26-30 (1992).
70. Youssoufian H, Pyeritz RE: Mechanisms and consequences of somatic mosaicism in humans. Nat Rev 3:748-758 (2002).
71. Yunis EJ, Zuniga J, Romero V, Yunis EJ: Chimerism and tetragametic chimerism in humans: implications in autoimmunity, allorecognition and tolerance. Immunol Res 38:213-236 (2007).
72. Zatz M, Marie SK, Passos-Bueno MR, Vainzof M, Campiotto S, et al: High proportion of new mutations and possible anticipation in Brazilian facioscapulohumeral muscular dystrophy families. Am J Hum Genet 56:99-105 (1995).